Article
An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
Thrombosis and haemostasis - 1 Feb 2013
Park Rojin, Ping Lifang, Song Jaewoo, Seo Joo-Young, Choi Tae-Youn, Choi Jong-Rak, Gorkun Oleg V, Lord Susan T
Abstract excerpt
A fibrin clot is stabilised through the formation of factor XIIIa-catalysed intermolecular ε-lysyl-γ-glutamyl covalent cross-links between α chains to form α polymers and between γ chains to form γ dimers. In a previous study we characterised fibrinogen Seoul II, a heterozygous dysfibrinogen in which a cross-linking acceptor site in Aα chain, Gln328, was replaced with Pro (AαQ328P). Following on the previous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
